RxDoctor Payments Data

John Ventrudo, MD

Physical Medicine & Rehabilitation · New York, NYNPI 1639376999

Payments from drug & device makers

$4,768in general payments, 2019–2025

Across 257 payments — averaging $18.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • Pacira Pharmaceuticals Incorporated$791
  • Collegium Pharmaceutical, Inc.$537
  • Valinor Pharma, LLC$241
  • Biodelivery Sciences International, Inc.$231
  • Scilex Pharmaceuticals Inc.$224
  • plus $1K from 13 others

What the payments were for

  • Travel & lodging$58712%
  • Food & beverage$4,18188%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,768 in reported general payments places this provider in the 90th percentile of 872 physical medicine & rehabilitation providers in New York.

See all physical medicine & rehabilitation providers in New York

Medicare billing

Part B allowed, 2024
$237,138
Medicare patients
183
Services billed
6,874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PercocetOxycodone Hcl/Acetaminophen17$99,210
RelistorMethylnaltrexone Bromide27$43,546
OxycontinOxycodone Hcl45$36,653
Xtampza ErOxycodone Myristate22$27,918
MovantikNaloxegol Oxalate64$25,708
Oxycodone Hcl296$8,673
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen259$5,396
Lidocaine64$4,975
Fentanyl26$3,403
Tizanidine Hcl123$3,052
Gabapentin309$3,013
Pregabalin103$1,790
Morphine Sulfate ErMorphine Sulfate50$1,452
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$1,296
Cyclobenzaprine Hcl152$1,267

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$1,643$43,54627 claims
Collegium Pharmaceutical, Inc.Xtampza Er$537$27,91822 claims
Redhill Biopharma Inc.Movantik$60$25,70864 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 872 physical medicine & rehabilitation providers in New York.

Other physical medicine & rehabilitation in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →